INO

#4128
Inovio Pharmaceuticals, Inc.
1.11 USD
+1.83%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
1.11
1.12
Rango anual
1.03
2.98
Cambio diario
+1.83%
Variación mensual
-33.53%
Variación en los últimos 6 meses
-55.24%
Cambio anual
-37.29%
Cierres anteriores
1.09
Abrir
1.11
Bid
Ask
Mínimo
1.11
High
1.12
Volumen
95
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 76.69 M
  • Employee 112
  • Founded 1999
  • CEO Jacqueline Shea
  • Website www.inovio.com
  • Headquarter Delaware, United States
  • FIGI BBG000BK6YX5
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.96
Relación precio/flujo de caja
1 248.52

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

Noticias